176 related articles for article (PubMed ID: 38344294)
1. Transmission potential of mpox in mainland China, June-July 2023: estimating reproduction number during the initial phase of the epidemic.
Akhmetzhanov AR; Wu PH
PeerJ; 2024; 12():e16908. PubMed ID: 38344294
[TBL] [Abstract][Full Text] [Related]
2. Supercritical and homogenous transmission of monkeypox in the capital of China.
Zhang Y; Zhou X
J Med Virol; 2024 Feb; 96(2):e29442. PubMed ID: 38294063
[TBL] [Abstract][Full Text] [Related]
3. Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study.
Zhang XS; Mandal S; Mohammed H; Turner C; Florence I; Walker J; Niyomsri S; Amirthalingam G; Ramsay M; Charlett A; Vickerman P
Lancet Infect Dis; 2024 Jan; 24(1):65-74. PubMed ID: 37708908
[TBL] [Abstract][Full Text] [Related]
4. Global prediction for mpox epidemic.
Zhang L; Huang J; Yan W; Zhao Y; Wang D; Chen B
Environ Res; 2024 Feb; 243():117748. PubMed ID: 38036205
[TBL] [Abstract][Full Text] [Related]
5. Modelling the impact of human behavior using a two-layer Watts-Strogatz network for transmission and control of Mpox.
Jia Q; Xue L; Sui R; Huo J
BMC Infect Dis; 2024 Mar; 24(1):351. PubMed ID: 38532346
[TBL] [Abstract][Full Text] [Related]
6. Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic.
Paredes MI; Ahmed N; Figgins M; Colizza V; Lemey P; McCrone JT; Müller N; Tran-Kiem C; Bedford T
Cell; 2024 Mar; 187(6):1374-1386.e13. PubMed ID: 38428425
[TBL] [Abstract][Full Text] [Related]
7. The risk of mpox importation and subsequent outbreak potential in Chinese mainland: a retrospective statistical modelling study.
Deng X; Tian Y; Zou J; Yang J; Sun K; Yu H
Infect Dis Poverty; 2024 Feb; 13(1):21. PubMed ID: 38419040
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.
Wang Y; Yu J; Wang F; Zhang Y; Ma S
Front Public Health; 2023; 11():1151038. PubMed ID: 37089485
[TBL] [Abstract][Full Text] [Related]
9. Assessing the transmission potential of mpox in East Asia during 2022-2023: A focus on Taiwan, China, Japan, and South Korea.
Kim M; Shim E
Int J Infect Dis; 2024 Jan; 138():110-112. PubMed ID: 38008354
[TBL] [Abstract][Full Text] [Related]
10. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
Wan H; Cui JA; Yang GJ
Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
[TBL] [Abstract][Full Text] [Related]
11. Modeling the complete spatiotemporal spread of the COVID-19 epidemic in mainland China.
Hu B; Ning P; Qiu J; Tao V; Devlin AT; Chen H; Wang J; Lin H
Int J Infect Dis; 2021 Sep; 110():247-257. PubMed ID: 33862212
[TBL] [Abstract][Full Text] [Related]
12. Lessons drawn from China and South Korea for managing COVID-19 epidemic: Insights from a comparative modeling study.
Tang B; Xia F; Bragazzi NL; McCarthy Z; Wang X; He S; Sun X; Tang S; Xiao Y; Wu J
ISA Trans; 2022 May; 124():164-175. PubMed ID: 35164963
[TBL] [Abstract][Full Text] [Related]
13. Global Mpox spread due to increased air travel.
Qiao H; Paansri P; Escobar LE
Geospat Health; 2024 Jun; 19(1):. PubMed ID: 38872388
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jun; ():. PubMed ID: 35765564
[TBL] [Abstract][Full Text] [Related]
15. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of the travel ban within mainland China on the epidemic of the COVID-19.
Xue L; Jing S; Sun W; Liu M; Peng Z; Zhu H
Int J Infect Dis; 2021 Jun; 107():278-283. PubMed ID: 33838344
[TBL] [Abstract][Full Text] [Related]
17. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
Elife; 2022 Aug; 11():. PubMed ID: 35938911
[TBL] [Abstract][Full Text] [Related]
18. Mpox: "the stigma is as dangerous as the virus". Historical, social, ethical issues and future forthcoming.
Orsini D; Sartini M; Spagnolo AM; Cristina ML; Martini M
J Prev Med Hyg; 2023 Dec; 64(4):E398-E404. PubMed ID: 38379747
[TBL] [Abstract][Full Text] [Related]
19. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
Aden D; Zaheer S; Kumar R; Ranga S
J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
[TBL] [Abstract][Full Text] [Related]
20. Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada.
Sachdeva H; Shahin R; Ota S; Isabel S; Mangat CS; Stuart R; Padhi S; Chris A; Mishra S; Tan DHS; Braukmann TW; Eshaghi A; Mejia EM; Hizon NA; Finkelstein M
J Infect Dis; 2024 Mar; 229(Supplement_2):S305-S312. PubMed ID: 38035826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
